Kristen Elam
Primary Care · Manchester, TNNPI 1407275225
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Novo Nordisk at 29.2% of the total. Reporting peaked in 2022 at $1,938 and has fallen 99.0% since, to $19 in 2025.
Across 248 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$379
- AstraZeneca$218
- Biohaven Pharmaceutical Holding Company Ltd.$213
- Lilly USA, LLC$151
- Merck$149
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,890100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 76 | $1,135 |
| AbbVie | 32 | $379 |
| AstraZeneca | 8 | $218 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $213 |
| Lilly USA, LLC | 9 | $151 |
| Merck | 10 | $149 |
| Sanofi-aventis U.S. LLC | 10 | $148 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Xeris Pharmaceuticals, Inc. | 6 | $129 |
| Amgen | 8 | $128 |
| GSK | 8 | $116 |
| Biohaven Pharmaceuticals, Inc. | 7 | $107 |
| Eisai Inc. | 7 | $97 |
| Boehringer Ingelheim | 6 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $72 |
| Insulet Corporation | 4 | $69 |
| Pfizer | 4 | $62 |
| Novartis | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Currax Pharmaceuticals LLC | 4 | $51 |
| Dexcom, Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Johnson & Johnson | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $21 |
| Bayer | 1 | $19 |
| Medtronic | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Genentech USA, Inc. | 2 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$106
How this compares
$3,890 in reported general payments places this provider in the 85th percentile of 189 primary care providers in Tennessee.
Other primary care in Manchester
- Janice BassManchester$7K
- Hanna CunninghamManchester$5K
- Amy WhiteManchester$4K
- Mary SullivanGermantown$115K
- Len GetzMemphis$25K
- Judith CaldwellNashville$18K
- Mara HutchingsNashville$14K
- Reena BhaktaMurfreesboro$12K
- Ryan HartmanNashville$11K
- Martha LemonsBrentwood$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.